Rankings / Phase 3 starts
Phase 3 starts
Sponsors ranked by the number of Phase 3 trials that started in the quarter.
Last revised
Ranking
| Rank | Sponsor | Quarter | Starts |
|---|---|---|---|
| 1 | Novo Nordisk A/S | 2026Q2 | 10 |
| 2 | Assistance Publique - Hôpitaux de Paris | 2026Q2 | 8 |
| 3 | AstraZeneca | 2026Q2 | 8 |
| 4 | Pfizer | 2026Q2 | 8 |
| 5 | Sun Yat-sen University | 2026Q2 | 7 |
| 6 | Beijing Tiantan Hospital | 2026Q2 | 6 |
| 7 | GlaxoSmithKline | 2026Q2 | 6 |
| 8 | Haisco Pharmaceutical Group Co., Ltd. | 2026Q2 | 6 |
| 9 | Hoffmann-La Roche | 2026Q2 | 6 |
| 10 | Merck Sharp & Dohme LLC | 2026Q2 | 6 |
| 11 | Qilu Pharmaceutical Co., Ltd. | 2026Q2 | 6 |
| 12 | Sichuan Baili Pharmaceutical Co., Ltd. | 2026Q2 | 6 |
| 13 | Colgate Palmolive | 2026Q2 | 5 |
| 14 | CSPC Megalith Biopharmaceutical Co.,Ltd. | 2026Q2 | 5 |
| 15 | Janssen Research & Development, LLC | 2026Q2 | 5 |
| 16 | AbbVie | 2026Q2 | 4 |
| 17 | Alliance for Clinical Trials in Oncology | 2026Q2 | 4 |
| 18 | Capital Medical University | 2026Q2 | 4 |
| 19 | Eurofarma Laboratorios S.A. | 2026Q2 | 4 |
| 20 | Fudan University | 2026Q2 | 4 |